Radiology
Holon: The Process Adaptive Interoperability Framework
July 12, 2010 11:37 am | by Bio-Medicine.Org | News | CommentsATLANTA , July 12 /- Holon, the new standard for healthcare interoperability, today announced general availability of its Medication Management solution. Leveraging the Holon Process Adaptive Interoperability Framework, Holon introduces a cost-effective alternative to your paper processes...
S.D. Firm Brings 1st Two Open, Faster MRI Scanners to County
July 11, 2010 11:34 pm | by San Diego Business Journal | News | CommentsMedical patients who need magnetic resonance imaging may find an oasis in the county's first two open, faster MRI scanners.
Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business
July 9, 2010 10:39 am | by Bio-Medicine.Org | News | CommentsRALEIGH, N.C. , July 9 /- Pioneer Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide sales and technical biologic expertise to support their growing line of products that address bone and soft tissue repair. Mr. Shane Ray , General Manager for...
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
July 8, 2010 1:37 pm | by Bio-Medicine.Org | News | CommentsNEW YORK , July 8 /- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment... This study encompasses feedback provided by U.S. physicians on...
FDA Consumer Health Information: Using Malaria Medication For Leg Cramps Is Risky
July 8, 2010 1:37 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , July 8 /PRNewswire-USNewswire/ -- People who use the malaria drug Qualaquin to treat or prevent nighttime leg cramps may want to talk to their health care professional. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:...
Stryker to Host Conference Call on July 20, 2010
July 7, 2010 12:35 pm | by Bio-Medicine.Org | News | CommentsKALAMAZOO, Mich. , July 7 /- Stryker Corporation (NYSE: SYK ) announced that it will host a conference call on Tuesday, July 20, 2010 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended June 30, 2010 , and provide an operational update. Operating...
FDA Launches Medical Device and Radiation-Emitting Product Transparency Website
July 7, 2010 11:34 am | Product Releases | CommentsThe FDA launched the Center for Devices and Radiological Health (CDRH) Transparency website as part of the agency’s transparency initiative.
Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules
July 7, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsJERUSALEM, Israel , July 7, 2010 /- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement (MSA) with sanofi-aventis. According to the MSA, sanofi-aventis will...
Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
July 7, 2010 8:35 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina http://www.reportlinker.com/p0186217/Stakeholder-Opinions-Vaccines-in...
Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
July 7, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity http://www.reportlinker.com/p0...
Renhuang Begins Trading on NYSE Amex
July 7, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsHARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that,...
Zweena Selects ITelagen to Host Personal Health Records Application
July 7, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsWEST WINDSOR, N.J. , July 7 /- ITelagen, a leading provider of electronic health record (EHR) hosting and management announced that it was selected by Zweena, LLC of West Windsor, NJ to host their Zweena Health Record, personal health record application. ITelagen, which was selected for...
Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries)
July 6, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 6 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) http://www.reportlinker.com/p0196554/European-Markets-for-Gastrointestin......
Reportlinker Adds Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities
July 6, 2010 6:36 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 6 /- Reportlinker.com announces that a new market research report is available in its catalogue: Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities http://www.reportlinker.com/p0233679/Surgical-Equipment-Market-to-2016--......
Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months
July 5, 2010 3:38 pm | by Bio-Medicine.Org | News | CommentsTEL AVIV, Israel , July 5, 2010 /- Neurim Pharmaceuticals ( http://www.Neurim.com ) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in...
MiMedx Group, Inc. Announces Release Date for Second Quarter Results
July 2, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsMARIETTA, Ga. , July 2 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the second quarter, ended June 30, 2010 , will be released before the opening of...
Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
July 2, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsMONTERREY, Mexico and ATLANTA , July 2 /- A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software . Using the arc-based Elekta VMAT delivery method,...
Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease
July 1, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsRICHMOND, Calif. , July 1 /- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has been awarded a second round of funding by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support studies in non-human primates for the development of a ZFP...
Aeras Global TB Vaccine Foundation Announces Appointment of Accomplished Pharmaceutical Executive as President and CEO
July 1, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsJames E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis ROCKVILLE, Md. , July 1 /PRNewswire-USNewswire/ -- The Aeras Global TB Vaccine Foundation today announced that James E. Connolly has been named President and Chief Executive Officer....
Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
July 1, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsBEIJING , July 1 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China , said today that Rita Zheng Liu , Chief Financial Officer, and Sam...
PartsSource Wins 2010 Venture of the Year Award
July 1, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsAURORA, Ohio , July 1 /- PartsSource, the world's #1 eBusiness Solution provider for replacement medical repair parts for hospital equipment, has been honored with the 2010 Venture of the Year Award for Northern Ohio . The Ohio Venture Association is a group of northeast Ohio...
China PharmaHub Corp. Enters Into Definitive Agreement for Humanized Antibody
July 1, 2010 11:32 am | by Bio-Medicine.Org | News | CommentsBOSTON , July 1 /- China PharmaHub Corp. ("PharmaHub"), announced today that it has entered into a definitive agreement with Dr. David Weaver and Dr. Michael Rynkiewicz . In addition, PharmaHub contemplates merging with World Wide Relics, Inc. (OTC Bulletin Board: WRLC) of which it...
Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTAâ„¢ for Men With Low Testosterone
July 1, 2010 12:33 am | by Bio-Medicine.Org | News | CommentsCHADDS FORD, Pa. , July 1 /- Endo Pharmaceuticals (Nasdaq: ENDP ) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for...
Shire Purchases Strategic Site in Massachusetts
June 30, 2010 10:33 am | by Bio-Medicine.Org | News | CommentsLEXINGTON, Massachusetts , June 30, 2010 /- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced its purchase of the Lexington Technology Park campus in Lexington, Massachusetts . The purchase signifies an investment in the growth of its...
Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R & D Facilities Across the United States
June 30, 2010 8:34 am | by Bio-Medicine.Org | News | CommentsBALTIMORE , June 30 /- GoIndustry DoveBid announces the Pfizer asset disposition program, which will see auctions of surplus assets from Pfizer's facilities across the United States . Over 500 lots per week will be available via online auction as part of GoIndustry DoveBid's ongoing...
